Tech Company Financing Transactions
Novosteo Funding Round
Novosteo, based in West Lafayette, secured $5.5 million in funding from BioCrossroads, Elevate Ventures and Kairos Ventures.
Transaction Overview
Company Name
Announced On
3/18/2021
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series A
Proceeds Purpose
Proceeds from the financing will be used to advance NOV004 into clinical development that will begin in the first half of 2021.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1281 Win Hentschel Blvd.
West Lafayette, IN 47906
USA
West Lafayette, IN 47906
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Approximately 6.3 million bone fractures occur each year in the United States. This problem is compounded by a generally aging population in which the frequency of osteoporosis and the rate of life-threatening fractures is dramatically increased. Hip fractures alone are expected to climb by 160% to 500,000 fractures per year by 2040.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Boyle
Chief Scientific Officer
Stewart Low
Browse more venture capital transactions:
Prev: 3/18/2021: Dutchie venture capital transaction
Next: 3/18/2021: 3DLOOK venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs